Thus, these findings propose a mechanism in which NAT10, through modulation of CCL25 and CCR9 dynamics, contributes to immune evasion in PCa by inhibiting CD8+ T cell recruitment and activity within the tumor microenvironment. The gene discussed is CCR9; the disease is neoplasm.